Silica nanowires conduct drugs into cells
New research has shown that silica nanowires can be used to deliver toxic agents into both human and bovine epithelial cell lines, opening up new options for drug targeting and delivery.
Archives for August 29, 2007
Sigma-Aldrich jump on the LentiExpress for RNAi screening
Sigma-Aldrich has launched a new technology that promises to dramatically simplify and speed-up high-throughput (HT) RNAi screening of the human kinome.
Dr Reddy's bets high on biosimilars
Indian drug maker Dr Reddy's is planning to launch one biosimilar every year in the next few years, according to Indian media reports.
Micromet sticks to tough cancer target
Micromet is sticking to its research into cell adhesion antibodies to treat breast cancer and other tumours, hoping it will have more luck than GlaxoSmithKline and Centocor's failed attempt.
Product news in brief - week 35
LabTechnologist.com brings you its periodic round up of new product releases and product news, with new offerings from Aura, Horiba Jobin Yvon, Integra, Metrohm, Millipore, Promega, Roche and Thermo Fisher Scientific.
SAFC Wisconsin site keeps on growing
In the latest phase of growth at chemical firm SAFC's flagship high potency active pharmaceutical ingredients (HPAPIs) facility in Madison, Wisconsin, the site will be treated to another multi-million dollar expansion and new analytical testing...
Week of drama for PDL Biopharma
PDL Biopharma has seen a week of drama after announcing a restructure that left its key investor calling for the company chairman to resign, a week after its CEO also decided to step down after similar pressure.
Clinical investment news round-up
Quintiles, WHI Capital Partners and Premier Research are the centre of fresh investment announcements in the clinical community this week.
Charles River, LAB put their faith in Canada
Two big players in the early stage contract research organisation (CRO) arena have announced this week they are expanding their preclinical capabilities in Canada as demand for preclinical testing is rising.
AstraZeneca's schizophrenia drug gets the nod in the Netherlands
AstraZeneca has had its new extended-release formulation of its schizophrenia drug approved in the Netherlands.
EU approval of new Rebif just what the doctor ordered
Merck Serono's new and improved version of its blockbuster multiple sclerosis (MS) drug Rebif (interferon beta-1a) has been approved in the EU, providing a little added protection to the company's MS franchise.
Lonza's China plan taking shape
Lonza's $200m (€147m) investment in China is continuing to shape up as the firm announced its new small-scale exclusive synthesis manufacturing plant will be up and running next month.